Ninlaro (ixazomib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ninlaro (ixazomib), covering 2023-02-08 to 2023-02-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM) [Phase 2]